Get Medical Devices every Monday

One free email with what the biggest companies in Medical Devices filed, were granted and gave up this week.

The Thicket.
Medical Devices / Week of Nov 16, 2026Get it every Monday →
All Medical DevicesIssue 001 / Abbott LaboratoriesThe filing
Abbott LaboratoriesGrant

Abbott Diabetes Care secures analyte monitoring patents and publishes guard ring and hypoglycemic risk technologies.

The filing

Abbott Diabetes Care Inc. received US patent 12788280 for analyte monitoring systems on November 10, 2026. The company also published applications for guard rings for on-body analyte sensors and a system to manage diabetes based on hypoglycemic risk on November 12, 2026, available at https://patentcenter.uspto.gov/applications/19665221 and https://patentcenter.uspto.gov/applications/19649893.

This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.

Expert view

ABBOTT DIABETES CARE INC. was granted US patent 12788280 (opens in a new tab), titled "SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING", on November 10, 2026. St. Jude Medical, Cardiology Division, Inc. was granted US patent 12788383 (opens in a new tab), titled "MEDICAL DEVICE HAVING EXPANDABLE AND COLLAPSIBLE OCCLUDING MEMBERS FOR TREATMENT OF ATRIAL SEPTAL DEFECTS", on November 10, 2026. Abbott Cardiovascular Systems Inc. was granted US patent 12788408 (opens in a new tab), titled "Tissue Fixation Devices And Methods", on November 10, 2026. St. Jude Medical, Cardiology Division, Inc. was granted US patent 12788464 (opens in a new tab), titled "SYSTEMS AND METHODS FOR ISOLATING WIRES IN ELECTROPORATION DEVICES", on November 10, 2026. ABBOTT DIABETES CARE INC.'s application US20260354713A1 (opens in a new tab), titled "GUARD RINGS FOR ON-BODY ANALYTE SENSORS", was published on November 12, 2026. Abbott Diabetes Care Inc.'s application US20260354770A1 (opens in a new tab), titled "SYSTEM AND METHOD TO MANAGE DIABETES BASED ON HYPOGLYCEMIC RISK", was published on November 12, 2026. Cardiovascular Systems, Inc.'s application US20260354852A1 (opens in a new tab), titled "PERIPHERAL INTRAVENOUS LITHOTRIPSY SYSTEM CAPABLE OF USE OVER 0.025 TO 0.095-INCH GUIDEWIRE", was published on November 12, 2026. St. Jude Medical, Cardiology Division, Inc.'s application US20260355458A1 (opens in a new tab), titled "Controllable Expandable Catheter", was published on November 12, 2026.

Sources (8)

Get Medical Devices every Monday.

© 2026 Fearn AI, Inc. All rights reserved.

Information from the public patent record, not legal advice.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.